UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome

Molecular neurodegeneration, 2017-09, Vol.12 (1), p.63-63, Article 63

2017

Volltextzugriff (PDF)

Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

Proceedings of the National Academy of Sciences - PNAS, 2017-09, Vol.114 (38), p.E7929-E7938

2017

Volltextzugriff (PDF)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics

PloS one, 2021-11, Vol.16 (11), p.e0260323-e0260323

2021

Volltextzugriff (PDF)

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use

Epilepsy & behavior, 2017-05, Vol.70 (Pt B), p.334-340

2017

Volltextzugriff (PDF)

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration

Acta neuropathologica, 2008-08, Vol.116 (2), p.141-146

2008

Volltextzugriff (PDF)

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

PloS one, 2017-04, Vol.12 (4), p.e0174630-e0174630

2017

Volltextzugriff (PDF)

High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

The FASEB journal, 2010-08, Vol.24 (8), p.2716-2726

2010

Volltextzugriff (PDF)

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease

Scientific reports, 2013-08, Vol.3 (1), p.2540-2540, Article 2540

2013

Volltextzugriff (PDF)

Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

The FASEB journal, 2011-12, Vol.25 (12), p.4127-4137

2011

Volltextzugriff (PDF)

Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

Journal of neurology, 2020-01, Vol.267 (1), p.214-227

2020

Volltextzugriff (PDF)

Raman Spectroscopy to Diagnose Alzheimer’s Disease and Dementia with Lewy Bodies in Blood

ACS chemical neuroscience, 2018-11, Vol.9 (11), p.2786-2794

2018

Volltextzugriff (PDF)

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

The FASEB journal, 2006-03, Vol.20 (3), p.419-425

2006

Volltextzugriff (PDF)

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease

Biochemical and biophysical research communications, 2006-10, Vol.349 (1), p.162-166

2006

Volltextzugriff (PDF)

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

Acta neuropathologica, 2009, Vol.117 (1), p.55-62

2009

Volltextzugriff (PDF)

Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's disease

Analyst (London), 2018-12, Vol.143 (24), p.5959-5964

2018

Volltextzugriff (PDF)

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Brain (London, England : 1878), 2009-04, Vol.132 (4), p.1093-1101

2009

Volltextzugriff (PDF)

Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: Client and treatment characteristics and associations with first-time treatment seeking

Drug and alcohol review, 2014-09, Vol.33 (5), p.565-571

2014

Volltextzugriff (PDF)

TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

Acta neuropathologica, 2011-12, Vol.122 (6), p.703-713

2011

Volltextzugriff (PDF)

Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples

Neuroscience letters, 2013-09, Vol.551, p.17-22

2013

Volltextzugriff (PDF)

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

Acta neuropathologica, 2009-11, Vol.118 (5), p.647-658

2009

Volltextzugriff (PDF)

Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease

The American journal of pathology, 1990-02, Vol.136 (2), p.255-260

1990

Volltextzugriff (PDF)

Secretory Form of Alzheimer Amyloid Precursor Protein 695 in Human Brain Lacks β/A4 Amyloid Immunoreactivity

Biochemical and biophysical research communications, 1993-03, Vol.191 (2), p.392-398

1993

Volltextzugriff (PDF)

Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage

Stroke (1970), 1990-03, Vol.21 (3), p.480-483

1990

Volltextzugriff (PDF)

Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy

Human pathology, 1990-12, Vol.21 (12), p.1221-1226

1990

Volltextzugriff (PDF)

Gerstmann-Sträussler-Scheinker disease showing β-protein type cerebellar and cerebral amyloid angiopathy

Acta neuropathologica, 1994-09, Vol.88 (3), p.262-266

1994

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome

Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease

Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

Raman Spectroscopy to Diagnose Alzheimer’s Disease and Dementia with Lewy Bodies in Blood

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

Blood-based near-infrared spectroscopy for the rapid low-cost detection of Alzheimer's disease

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Dedicated 'cannabis only' treatment clinics in New South Wales, Australia: Client and treatment characteristics and associations with first-time treatment seeking

TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration

Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease

Secretory Form of Alzheimer Amyloid Precursor Protein 695 in Human Brain Lacks β/A4 Amyloid Immunoreactivity

Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage

Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy

Gerstmann-Sträussler-Scheinker disease showing β-protein type cerebellar and cerebral amyloid angiopathy

Aktive Filter

Suchergebnisse filtern